Mirati Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Mirati Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2013 to Q3 2023.
  • Mirati Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2023 was $718M, a 20.4% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $718M -$184M -20.4% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $650M -$266M -29.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $660M -$361M -35.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $849M -$230M -21.3% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $902M -$9.65M -1.06% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $916M -$63K -0.01% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.02B +$64.1M +6.7% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.08B +$574M +114% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $912M +$464M +104% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $916M +$402M +78.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $958M +$467M +95.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $505M +$136M +36.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $448M +$85.3M +23.5% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $514M +$281M +120% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $491M +$264M +117% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $369M +$178M +93.9% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $362M +$236M +188% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $233M +$79.2M +51.4% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $226M +$98.3M +76.7% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $190M +$147M +341% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $126M +$71.7M +132% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $154M +$86.3M +127% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $128M +$52.4M +69.2% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $43.1M +$8.78M +25.6% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $54.2M +$998K +1.88% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $67.9M +$1.11M +1.67% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $75.7M +$2.59M +3.54% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $34.4M -$38.5M -52.8% Dec 31, 2016 10-K 2018-03-08
Q3 2016 $53.2M +$25M +89% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $66.8M +$21.3M +46.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $73.1M +$19.4M +36.1% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $72.8M +$50.1M +221% Dec 31, 2015 10-K 2017-03-09
Q3 2015 $28.1M -$4.66M -14.2% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $45.5M +$6.6M +17% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $53.7M +$8.66M +19.2% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $22.7M -$25.1M -52.5% Dec 31, 2014 10-K 2016-03-09
Q3 2014 $32.8M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $38.9M Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $45.1M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $47.8M Dec 31, 2013 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.